1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Global Drug Device Combination Products Market 2015-2019

Global Drug Device Combination Products Market 2015-2019

  • November 2015
  • -
  • Infiniti Research Limited
  • -
  • 74 pages

Summary

Table of Contents

Search Inside

About drug device combination products
Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine.

Technavio's analysts forecast the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.

Covered in this report
The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type:
- Drug eluting stent
- Prefilled syringes
- Wearable injectors
- Insulin delivery systems

Technavio's report, Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- Abbott Laboratories
- Becton, Dickinson and Company
- Boston Scientific
- Medtronic
- Roche Diagnostics

Other prominent vendors
- Aerogen
- Airon
- Allied Healthcare Products
- AstraZeneca
- B. Braun Medical
- BIOTRONIK
- Boehringer Ingelheim
- Briggs Healthcare
- C.R. Bard
- Cardinal Health
- Clement Clarke International
- Concordia
- Consort Medical
- Cook Medical
- DeVilbiss Healthcare
- Ethicon
- Gerresheimer
- GlaxoSmithKline
- Heyer Medical
- Invacare
- Lepu Medical Technology
- Mallinckrodt
- Medline Industries
- MicroPort Scientific
- Mylan
- Nypro
- Omron Healthcare
- PARI Medical
- Phillips Healthcare
- RPC Bramlage
- Salter Labs
- Smart inhaler
- Stryker
- Sunovion Pharmaceuticals
- Teleflex
- Terumo
- Vortran Medical
- W. L. Gore & Associates

Key market driver
- Use of home healthcare devices
- For a full, detailed list, view our report

Key market challenge
- High spending by patients
- For a full, detailed list, view our report

Key market trend
- Use of bioabsorable stents
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • $ 6500
  • Industry report
  • February 2017
  • by P&S Market Research

Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...

Chronic Kidney Disease (CKD) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Chronic Kidney Disease (CKD) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • March 2017
  • by Transparency Market Research

Chronic Kidney Disease (CKD) Drugs Market (Drug Class - ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Erythropoiesis - stimulating Agents (ESAs), and Diuretics; ...

Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer, Geography & Qualitative Assessment - Forecasts to 2021

Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer, Geography & Qualitative Assessment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global cholesterol testing services market is expected to reach USD 17.5 billion by 2021 from USD 11.9 billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.